ストックスクリーナーアプリを入手
0.9964
0.97%
-0.0336
前日終値:
$1.03
開ける：
$1.03
24時間の取引高:
43,921
Relative Volume:
0.32
時価総額：
$4.48M
収益：
$9.37M
当期純損益:
$-8.45M
株価収益率:
-1.2301
EPS:
-0.81
ネットキャッシュフロー:
$-7.27M
1週間 パフォーマンス:
-1.92%
1か月 パフォーマンス:
+36.00%
6か月 パフォーマンス:
-85.77%
1年 パフォーマンス:
-91.16%
1日の値動き範囲:
$0.9876
$1.07
1週間の範囲:
$0.943
$1.08
52週間の値動き範囲:
$0.693
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
名前
Bioaffinity Technologies Inc
セクター
電話
210-698-5334
住所
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.9964 | 4.63M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
513.68 | 192.62B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
200.00 | 144.77B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
618.25 | 51.65B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
117.25 | 34.09B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.99 | 31.30B | 3.17B | 642.63M | 516.49M | 10.77 |
Bioaffinity Technologies Inc (BIAF) 最新ニュース
BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now? - Finviz
bioAffinity Technologies, Inc. (BIAFW) Competitors - Meyka
bioAffinity presents asthma therapy matching research at AAAAI - Investing.com
bioAffinity Showcases Sputum-Based Platform for Personalized Asthma Care - TipRanks
bioAffinity presents asthma therapy matching research at AAAAI By Investing.com - Investing.com Australia
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study - ADVFN Ltd
bioAffinity presents poster showing sputum test can ID receptors for leading asthma biologics - TradingView
bioAffinity Technologies (NASDAQ: BIAF) shows asthma and COPD diagnostic data - Stock Titan
bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients - Yahoo Finance
BIAFW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is bioAffinity Technologies Inc. affected by consumer sentimentJuly 2025 Recap & Safe Capital Growth Tips - mfd.ru
Is bioAffinity Technologies Inc stock heavily shorted2025 Geopolitical Influence & Verified Swing Trading Watchlists - baoquankhu1.vn
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - The Chronicle-Journal
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test - BioSpace
bioAffinity launches study to test lung cancer diagnostic By Investing.com - Investing.com Australia
bioAffinity launches study to test lung cancer diagnostic - Investing.com
bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample - PharmiWeb.com
bioAffinity Launches New CyPath Lung Validation Study - TipRanks
Bioaffinity announces validation study for lung cancer test - marketscreener.com
New CyPath Lung validation study at BAMC by bioAffinity (BIAF) - Stock Titan
bioAffinity Adjourns Special Stockholder Meeting for Lack Quorum - MSN
bioAffinity Technologies (NASDAQ:BIAF) Stock Price Down 13.8% – Here’s What Happened - Defense World
Buyback Watch: Is bioAffinity Technologies Inc Equity Warrant stock overvalued or fairly pricedNew Guidance & Technical Pattern Based Buy Signals - baoquankhu1.vn
Can bioAffinity Technologies Inc. Equity Warrant weather a recessionTrade Analysis Summary & Reliable Volume Spike Trade Alerts - mfd.ru
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer - BioSpace
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Bur - PharmiWeb.com
bioAffinity Highlights CyPath Lung Case Study in Diagnostics - TipRanks
BioAffinity Technologies, Inc. Releases New Clinical Study Results - marketscreener.com
bioAffinity Highlights CyPath Lung Clinical Utility in Surveillance - TipRanks
Setup Watch: What is bioAffinity Technologies Inc Equity Warrants valuation compared to sectorForecast Cut & Precise Swing Trade Alerts - baoquankhu1.vn
How bioAffinity Technologies Inc. Equity Warrant stock performs in weak economyMarket Sentiment Summary & Risk Controlled Daily Trade Plans - mfd.ru
Is bioAffinity Technologies Inc.’s growth already priced in - mfd.ru
BIAF Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Growth Recap: Will bioAffinity Technologies Inc outperform tech stocksTrade Ideas & Technical Buy Zone Confirmations - baoquankhu1.vn
Will bioAffinity Technologies Inc. benefit from AI trends2025 Investor Takeaways & Low Volatility Stock Suggestions - mfd.ru
Momentum Shift: What is the implied volatility of bioAffinity Technologies IncEntry Point & Intraday High Probability Alerts - baoquankhu1.vn
bioAffinity Technologies Updates Investor Presentation Materials Online - The Globe and Mail
Can bioAffinity Technologies Inc. stock continue upward trendTrade Analysis Report & Accurate Buy Signal Notifications - mfd.ru
bioAffinity Technologies (BIAF) furnishes February 2026 presentation materials in 8-K - Stock Titan
bioAffinity Technologies expands medical advisory board with lung experts By Investing.com - Investing.com South Africa
bioAffinity Adds Leading Lung Cancer Experts to Advisory Board - TipRanks
bioAffinity Technologies Appoints New Advisory Board Members - TradingView
bioAffinity Technologies Appoints Three Physicians to Medical and Scientific Advisory Board - citybiz
bioAffinity Technologies expands medical advisory board with lung experts - Investing.com
BioAffinity Technologies, Inc. Announces Medical and Scientific Advisory Board Appointments - marketscreener.com
bioAffinity Sets 2026 Annual Meeting, Revives Prior Proposals - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
AI Stocks: Is bioAffinity Technologies Inc affected by consumer sentimentWeekly Risk Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
Bank Watch: Will bioAffinity Technologies Inc benefit from sector rotationJuly 2025 Fed Impact & Fast Entry Momentum Alerts - baoquankhu1.vn
Gainers Report: Can bioAffinity Technologies Inc Equity Warrant outperform under higher oil prices2025 Winners & Losers & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Bioaffinity Technologies Inc (BIAF) 財務データ
収益
当期純利益
現金流量
EPS
2.02%
0.04%
大文字化:
|
ボリューム (24 時間):